Matthäus Felsenstein

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
VEGF is an important factor in tumor vascularization and used as target for anti-angiogenic treatment strategies in glioma. In this study, we demonstrate for the first time that VEGF is a modulator of the innate immune response with suppressive effects on the immunologic and pro-angiogenic function of microglia/macrophages in a glioblastoma rodent model.(More)
  • 1